Home › Trial NCT00625768
Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma
- Trial IDNCT00625768
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorAntisoma Research
- Enrollment13
- Start date2008-01
- ConditionsMetastatic Renal Cell Carcinoma · Metastatic Malignant Melanoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.